4th Quarter - Report

GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Period 4th Quarter 2009 Filed Jan 20, 2010 Signed by Cristin Lis

Official filing
Firm
GILEAD SCIENCES, INC.
Client
GILEAD SCIENCES INC
Income
—
Expenses
$370,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Domestic HIV Policy issues (H.R.2137 - Routine HIV/AIDS Screening Coverage Act; Ryan White HIV/AIDS Treatment Extension Act; HIV Prevention.); Health Care Reform (H.R.3590 - Patient Protection and Affordable Care Act; H.R.3962 - Affordable Health Care for America Act, S.1679 - Affordable Health Choices Act.); International Trade and Intellectual Property Rights issues; International HIV and Health issues.

LobbyistCovered position, as disclosed
CRISTIN LIS —

Contacted: State, Dept of (DOS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS)

Bills named: H.R. 2137 (111th), H.R. 3962 (111th), H.R. 3590 (111th), S. 1679 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.